Arasanz, H.; Zuazo, M.; Bocanegra, A.; Chocarro, L.; Blanco, E.; MartÃnez, M.; Morilla, I.; Fernández, G.; Teijeira, L.; Morente, P.;
et al. Hyperprogressive Disease: Main Features and Key Controversies. Int. J. Mol. Sci. 2021, 22, 3736.
https://doi.org/10.3390/ijms22073736
AMA Style
Arasanz H, Zuazo M, Bocanegra A, Chocarro L, Blanco E, MartÃnez M, Morilla I, Fernández G, Teijeira L, Morente P,
et al. Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences. 2021; 22(7):3736.
https://doi.org/10.3390/ijms22073736
Chicago/Turabian Style
Arasanz, Hugo, Miren Zuazo, Ana Bocanegra, Luisa Chocarro, Ester Blanco, Maite MartÃnez, Idoia Morilla, Gonzalo Fernández, LucÃa Teijeira, Pilar Morente,
and et al. 2021. "Hyperprogressive Disease: Main Features and Key Controversies" International Journal of Molecular Sciences 22, no. 7: 3736.
https://doi.org/10.3390/ijms22073736
APA Style
Arasanz, H., Zuazo, M., Bocanegra, A., Chocarro, L., Blanco, E., MartÃnez, M., Morilla, I., Fernández, G., Teijeira, L., Morente, P., Echaide, M., Castro, N., Fernández, L., Garnica, M., Ramos, P., Escors, D., Kochan, G., & Vera, R.
(2021). Hyperprogressive Disease: Main Features and Key Controversies. International Journal of Molecular Sciences, 22(7), 3736.
https://doi.org/10.3390/ijms22073736